Abstract:CMR techniques are increasingly being used to evaluate myocardial extracellular volume (ECV). In the most commonly applied method, ECV is quantified using haematocrit-adjusted myocardial and blood T1 values measured before and after gadolinium bolus. The technique is based on a two-compartment model, which assumes contrast kinetic effects to be negligible due to a dynamic equilibrium between blood and myocardium (Dynamic-Equilibrium CMR; DynEq-CMR). This study assessed the effect of contrast dose, post-contrast acquisition time, myocardial regionality, cardiac cycle and gender on DynEq-CMR ECV measurement. 30 healthy volunteers (asymptomatic, no cardiovascular risk factors, normal examination and ECG) were prospectively split into 3 age and sex-matched groups (there were also no differences in mean eGFR, body surface area, heart rate, LV mass and volumetrics between groups): Group A received 0.10 mmol/kg Gd-DTPA, Group B 0.15 mmol/kg and Group C 0.20 mmol/kg. Mid-ventricular short-axis modified look locker inversion recovery (MOLLI) imaging was performed at 1.5T before, and at 2 min intervals between 2–20 min after, contrast administration, with same-day haematocrit measurement. MOLLI imaging was repeated in early systole (150 ms after R wave) pre- and at 10 min post-contrast. Resulting pixelwise T1 maps (figure 1; T1 maps at selected time-points are shown) were used to calculate ECV (Matlab). (Phantom studies performed prior to patient scanning determined T1 measurement accuracy and heart-rate correction algorithm). Figure 1 Pre-contrast myocardial (A 1051±49 ms; B 1045±49 ms; C 1040±43 ms; p=0.87) and blood (A 1678±98 ms; B 1645±118 ms; C 1686±101 ms; p=0.66) T1 times did not differ significantly between groups. Mean myocardial (A 542±65 ms; B 465±69 ms; C 407±55 ms; p<0.001) and blood (A 407±73 ms; B 307±67 ms; C 252±48 ms; p<0.001) T1 averaged over all time points post-contrast shortened significantly as contrast dose increased (figure 2). Mean ECV was significantly higher in group A compared to groups B and C (A 27.7±3.7%; B 25.8±3.4%; C 25.8±2.8%; p<0.001). The difference between groups B and C was not significant. ECV increased linearly over time in each group; between 2 and 20 min post-contrast, ECV increased from 27.2±2.7% to 28.8±3.4%, p=0.020 in group A; 25.3±2.8% to 26.5±3.2%, p=0.004 in group B; and 25.2±1.7% to 26.2±2.1%, p=0.068 in group C. ECV varied significantly between myocardial regions, being highest in the septum and lowest in the lateral wall in each group. ECV did not differ significantly between diastole and systole. ECV was significantly higher in females in each group (A female 29.6±3.0%, male 25.4±3.0%, p<0.001; B female 27.4±2.7%, male 23.6±2.9%, p<0.001; C female 26.1±2.8%, male 24.7±2.5%, p=0.027). Figure 2 The small increase in ECV over time suggests that an incomplete dynamic equilibrium between blood and myocardium is achieved. DynEq-CMR-derived ECV varies according to contrast dose, myocardial region and gender.

Contrast-optimized Composite Image Derived from Multigradient Echo Cardiac Magnetic Resonance Imaging Improves Reproducibility of Myocardial Contours and T2* Measurement

Free-breathing, Non-Ecg, Simultaneous Myocardial T1 , T2 , T2 *, and Fat-Fraction Mapping with Motion-Resolved Cardiovascular MR Multitasking.

High Spatial-Resolution and Acquisition-Efficiency Cardiac MR T1 Mapping Based on Radial bSSFP and a Low-Rank Tensor Constraint

Cardiac T2 * mapping: Techniques and clinical applications

Novel MRI T 2 Mapping for Improved Myocardial Tissue Characterisation

The Role of Improved Motion-Sensitized Driven Equilibrium Blood Suppression and Fat Saturation on T2 Relaxation Time, Using GraSE Sequence in Cardiac Magnetic Resonance Imaging

Feasibility of T 2 * Estimation with Chemical Shift-Based Water-Fat Separated Cardiac Imaging

Dose correction for post-contrast T1 mapping of the heart: the MESA study

Improved MRI T2 Relaxometry for Myocardial Tissue Characterisation

Free-Breathing Non-Contrast T1ρ Dispersion MRI of Myocardial Interstitial Fibrosis in Comparison with Extracellular Volume Fraction

Review of T1 Mapping Methods: Comparative Effectiveness Including Reproducibility Issues

Accelerated Cartesian Cardiac T2 Mapping Based on a Calibrationless Locally Low-Rank Tensor Constraint

Combination of Contrast-Enhanced Cardiac MR and Nuclear Myocardial Imaging in Evaluation of Myocardial Viability in Ischemic Cardiomyopathy

Myocardial perfusion cardiovascular magnetic resonance: optimized dual sequence and reconstruction for quantification

Head-to-head comparison of multiple cardiovascular magnetic resonance techniques for the detection and quantification of intramyocardial haemorrhage in patients with ST-elevation myocardial infarction

084 EFFECT OF CONTRAST DOSE, POST-CONTRAST ACQUISITION TIME, MYOCARDIAL REGIONALITY, CARDIAC CYCLE AND GENDER ON DYNAMIC-EQUILIBRIUM CONTRAST CMR MEASUREMENT OF MYOCARDIAL EXTRACELLULAR VOLUME

086 THE DETECTION OF ACUTE MYOCARDITIS USING CARDIOVASCULAR MRI: A CLINICAL STUDY COMPARING T1-MAPPING, T2-WEIGHTED AND LATE GADOLINIUM ENHANCEMENT IMAGING

On the loss of image contrast in double-inversion-recovery prepared T2* MRI of Intramyocardial hemorrhage

Myocardial extracellular volume fraction quantification based on T1 mapping at 3 T: quality optimization by contour-based registration and segmental analysis

Myocardial Characterization with Extracellular Volume Mapping with a First-Generation Photon-counting Detector CT with MRI Reference

Myocardial T2* Imaging at 3T and 1.5T: A Pilot Study with Phantom and Normal Myocardium